IDEAYA Biosciences, Inc. - Common Stock (IDYA)

Historical Holders from Q2 2019 to Q3 2025

Symbol
IDYA on Nasdaq
Type / Class
Equity / Common Stock
Shares outstanding
88,059,438
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
94,076,178
Holdings value
$2,559,825,306
% of all portfolios
0%
Number of holders
220
Number of buys
125
Number of sells
-88
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of IDEAYA Biosciences, Inc. - Common Stock (IDYA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 8.1% -16% $135,978,768 -$23,753,077 7,130,507 -14.9% BlackRock, Inc. 31 Mar 2025
Capital Research Global Investors 7.5% $137,737,565 6,552,691 Capital Research Global Investors 30 Jun 2025
JANUS HENDERSON GROUP PLC 7.3% +5.71% $174,915,104 +$6,043,368 6,428,339 +3.58% JANUS HENDERSON GROUP PLC 30 Sep 2025
Point72 Asset Management, L.P. 5% $80,218,014 4,412,432 Point72 Asset Management, L.P. 06 Jun 2025

Institutional Holders of IDEAYA Biosciences, Inc. - Common Stock (IDYA)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 94,076,178 $2,559,825,306 -$71,223,529 $27.21 220
2025 Q2 96,817,428 $2,035,216,946 +$85,041,555 $21.02 201
2025 Q1 93,850,250 $1,541,886,881 +$4,216,022 $16.38 204
2024 Q4 91,956,771 $2,362,946,798 -$39,164,259 $25.70 204
2024 Q3 91,887,231 $2,910,570,888 +$266,023,831 $31.68 208
2024 Q2 82,498,020 $2,896,457,095 +$112,714,519 $35.11 197
2024 Q1 79,029,194 $3,467,731,111 +$578,501,456 $43.88 202
2023 Q4 66,135,600 $2,353,088,646 +$312,448,429 $35.58 155
2023 Q3 59,708,967 $1,610,925,530 +$91,466,602 $26.98 143
2023 Q2 56,594,046 $1,329,917,026 +$272,378,345 $23.50 138
2023 Q1 45,571,754 $625,396,958 -$7,022,953 $13.73 127
2022 Q4 45,969,604 $835,255,954 +$24,122,546 $18.17 117
2022 Q3 44,731,101 $667,335,427 +$139,348,641 $14.92 111
2022 Q2 35,430,856 $488,943,386 +$8,388,194 $13.80 95
2022 Q1 34,963,082 $391,248,464 -$45,848,010 $11.19 100
2021 Q4 34,726,651 $820,669,496 +$42,947,568 $23.64 108
2021 Q3 32,866,465 $837,907,234 +$191,179,767 $25.49 90
2021 Q2 25,401,939 $533,388,213 +$25,544,214 $20.99 83
2021 Q1 23,772,357 $605,123,340 +$111,002,539 $23.50 87
2020 Q4 20,283,687 $283,967,278 +$21,355,133 $14.00 81
2020 Q3 18,878,265 $237,100,196 +$3,530,187 $12.56 66
2020 Q2 18,472,023 $262,487,409 +$120,236,682 $14.21 64
2020 Q1 10,920,611 $44,992,000 -$1,201,515 $4.12 24
2019 Q4 11,151,290 $83,635,000 -$5,010,818 $7.50 27
2019 Q3 5,572,657 $49,467,000 -$827,584 $9.00 24
2019 Q2 5,653,725 $56,312,000 +$56,312,000 $9.96 24